Evidence map›Paper›PMID 42370021›Full record

ArticleIranian journal of medical sciences2026

Mahin Homayoon, Davood Mehrabani, Mohammad Amin Edalatmanesh, Mehrdad Shariati, Masood Amini

Abstract read
In one paragraph

Article in Iranian journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahin HomayoonDepartment of Biology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Davood MehrabaniStem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Amin EdalatmaneshDepartment of Biology, Shiraz Branch, Islamic Azad University, Shiraz, Iran.
Mehrdad ShariatiDepartment of Biology, Zand Institute of Higher Education, Shiraz, Iran.
Masood AminiLaparoscopy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adipose tissue-derived stem cells (AdSCs) are widely used for regenerative medicine purposes. There is always a need to accelerate cell proliferation and protect the cells from apoptosis when cell transplantation, especially AdSCs, is targeted. Therefore, this study evaluated the effect of lithium chloride on the proliferation and growth kinetic of AdSCs. Methods: The study was undertaken in the Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, in 2020. Adipose tissue specimens were provided from the abdominal region of a 35-year-old woman. In an Results: AdSCs showed mesenchymal characteristics, and lithium chloride at a dose of 6 µM had an increasing impact on cell proliferation and protected the cells from apoptosis. A non-significant increase in expression of the Conclusion: Our findings indicate that the addition of lithium chloride to the culture medium enhanced the proliferation of AdSCs and protected them against apoptosis.

Indexed as

Lithium ChlorideMesenchymal Stem CellsAbdominal FatAdultApoptosisbcl-2-Associated X ProteinCell ProliferationCulture MediaFemaleGene Expression RegulationHumansPrimary Cell CultureProto-Oncogene Proteins c-bcl-2Regenerative MedicineBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanCulture MediaLithium ChlorideProto-Oncogene Proteins c-bcl-2Adipose tissueCell proliferationLithium chlorideMesenchymal stem cellsRegenerative medicine

Identifiers

PMID42370021
PMCPMC13309734

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.